Helsinn and Mundipharma China Pharmaceutical jointly announce ...
LUGANO, Switzerland and BEIJING, Sept. 25, 2019 /PRNewswire-AsiaNet/ -- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Mundipharma China Pharmaceutical, the market leader in pain management, today jointly announce that the National Medical Products Administration (NMPA) has...
Authors: LATEST ASIANET NEWS RELEASES